Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Myelodysplastic Syndromes 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Non-Hodgkin 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Hodgkin Disease 10Myeloproliferative Disorders 9Lymphoma, Mantle-Cell 9Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Prolymphocytic 8Leukemia, Myeloid, Chronic-Phase 7Waldenstrom Macroglobulinemia 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Chronic 6Burkitt Lymphoma 6Leukemia, Biphenotypic, Acute 5Anemia, Refractory, with Excess of Blasts 5Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma 4Leukemia, Monocytic, Acute 4Sezary Syndrome 3Recurrence 3Primary Myelofibrosis 3Mycosis Fungoides 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Megakaryoblastic, Acute 3

Interventions

Docetaxel 137Prednisone 120Abiraterone Acetate 91Leuprolide 86enzalutamide 84Radiotherapy 59bicalutamide 56Magnetic Resonance Spectroscopy 54Goserelin 54Androgen Antagonists 51acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47apalutamide 44abiraterone 34Radiosurgery 31Specimen Handling 30gallium 68 PSMA-11 29Gonadotropin-Releasing Hormone 29cabazitaxel 28Carboplatin 27darolutamide 26Estramustine 24luprolide acetate gel depot 23relugolix 22Metformin 22Triptorelin Pamoate 20sipuleucel-T 19radium Ra 223 dichloride 19Radiation 19pembrolizumab 18deltacortene 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Prostatic Neoplasms × Cyclosporins × Clear all
NCT00824811 2012-08-02

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

M.D. Anderson Cancer Center

Phase 2 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Lacrimal Apparatus Diseases, Lung Neoplasms, Endophthalmitis, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Lacerations, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡